Indian Journal of Diabetes and Endocrinology
Full Text (PDF)
Licence:
Indian Journal of Diabetes and Endocrinology 3(1):p 9-13, . | DOI:
Original Article
Impact of Myoinositol in Polycystic Ovarian Syndrome
Author Information
Licence:
Indian Journal of Diabetes and Endocrinology 3(1):p 9-13, . | DOI:
How Cite This Article:
Wajeeda Tabasum, Roya Rozati, Ayapati Gautam Mehdi, et al./Impact of Myoinositol in Polycystic Ovarian Syndrome/Indian Journal of Diabetes and Endocrinology, 2021;3(1):9–13.
Received : N/A
Accepted : N/A
Published : N/A
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility and metabolic problems among women of reproductive age. Myo inositol (MI) is administered in women with polycystic ovary syndrome (PCOS) over the last few years. It plays an important role in many metabolic pathways if the function is impact which affects the human health. Many hormonal and reproductive disorders associated with this disorder seem relieved by the supplement. The main symptom seems to be an increased androgen concentration, which in turn may contribute to different metabolic disorders which is improved in women with PCOS by supplementation of MI. Administration of MI is a safe and effective option to prevent and correct metabolic disorders in teenagers affected by PCOS. Thus, the aim of this review is to present the effectiveness of MI in the treatment for PCOS symptoms.
References (Bibliographical note)
No records found.
Funding Details
Author Information
Authors and Affiliatione
- Roya Rozati,
, -
,
Rights & Permissions
Search for Similar Articles
You may search for similar articles that contain these
Article Level Metrics
Last UpdatedSaturday 19 April 2025, 05:37:30 (IST)
3
Accesses
00
0
00
Citations
22
11
23
View full article metrics including social shares, article views and publishing history
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | N/A |
| Accepted | N/A |
| Published | N/A |